The Helsinki Declaration 2020: Europe that protects.
Jaana I Halonen, Marina Erhola, Eeva Furman...
https://pubmed.ncbi.nlm.nih.gov/33159874/Actively Recruiting
Led by Universidad de La Frontera · Updated on 2026-04-02
116
Participants Needed
1
Research Sites
4 weeks
Total Duration
Researchers are studying the sustainability of two anesthetic techniques used during coronary artery bypass graft surgery in adults with coronary artery disease. This study compares an optimized recovery anesthetic method designed to reduce complications, speed up extubation, shorten ICU stays, and lower costs, against the usual anesthetic practice. The research also addresses the environmental impact of anesthesia, as operating rooms contribute significantly to greenhouse gas emissions and resource use, posing challenges for sustainable healthcare. The optimized recovery approach includes giving oral pregabalin before surgery, fasting protocols, avoiding benzodiazepines, using total intravenous anesthesia with low-dose fentanyl and methadone, and performing an erector spinae plane block. Postoperative care involves scheduled paracetamol and NSAIDs with methadone as needed. The standard practice group receives anesthesia as routinely administered by most anesthesiologists without protocol changes. Four anesthesiologists participate, with one applying the optimized technique and three using standard practice, based on the hospital schedule. Participants will undergo elective coronary artery bypass graft surgery and be followed from operating room entry until extubation in the ICU. Data collected include clinical details, anesthesia drugs and duration, resource use, surgical times, ICU extubation times, and costs. Environmental impact will be assessed through a life-cycle analysis measuring CO2 emissions and related health damage. The main outcome combines costs, environmental impact, and extubation time to evaluate the sustainability of each anesthetic approach.
CONDITIONS
Sustainable Anesthesia in Myocardial Revascularization Surgery.
W
Waldo Merino, MSc
C
Claudio Cárcamo, MSc
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Universidad de La Frontera
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Up to several days including surgery and ICU stay
Participants undergo myocardial revascularization surgery with either the standard anesthetic practice or the optimized recovery anesthetic technique, followed by immediate care in the intensive care unit (ICU) focusing on early extubation and recovery.
1 surgical procedure and continuous ICU monitoring until extubation
Duration - Until hospital discharge after surgery
Participants are monitored after surgery to assess clinical effectiveness, environmental impact, and costs associated with the anesthetic technique used during the surgery.
Visits as part of routine hospital care until discharge
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Jaana I Halonen, Marina Erhola, Eeva Furman...
https://pubmed.ncbi.nlm.nih.gov/33159874/Andrea J MacNeill, Robert Lillywhite, Carl J Brown
https://pubmed.ncbi.nlm.nih.gov/29851650/Daniel Grinberg, Rémi Buzzi, Matteo Pozzi...
https://pubmed.ncbi.nlm.nih.gov/34411226/J C Kubitz, A-M Schubert, L Schulte-Uentrop
https://pubmed.ncbi.nlm.nih.gov/35987897/Christin Seifert, Lisa Koep, Patrick Wolf...
https://pubmed.ncbi.nlm.nih.gov/31116121/Jonathan Drew, Sean D Christie, Peter Tyedmers...
https://pubmed.ncbi.nlm.nih.gov/34251875/Noémie Simon-Tillaux, Guillaume L Martin, David Hajage...
https://pubmed.ncbi.nlm.nih.gov/39532374/Jaana I Halonen, Marina Erhola, Eeva Furman...
https://pubmed.ncbi.nlm.nih.gov/33307082/Kerstin Wyssusek, Ka Lo Chan, Gerard Eames...
https://pubmed.ncbi.nlm.nih.gov/36002191/Matthew J Eckelman, Jodi D Sherman
https://pubmed.ncbi.nlm.nih.gov/29072942/Universidad de La Frontera
Lead Sponsor